Krishna Ghimire profile picture
Accepting New Patients
315 464-8200

Krishna Ghimire, MD

CURRENT APPOINTMENTS

Assistant Professor of Medicine

SPECIALTIES

Internal Medicine
Hematology
Medical Oncology

LANGUAGES

English
Hindi
Nepali
Bengali

PATIENT TYPE

Adults

CLINICAL TRIALS

64407564MMY3009 - MonumenTAL-6: A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and Investigator’s Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants with Relapsed or Refractory Myeloma who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide
Read more
I-501719 - A Phase II Study of CPX-351 in Younger Patients (< 60 Years Old) with Secondary Acute Myeloid Leukemia
Read more
54767414NAP4001: A Post-authorization Safety Study to Evaluate the Incidence of and Risk Factors for Severe and Fatal Infusion-related Reactions in Participants Treated with Daratumumab (Intravenous or Subcutaneous)
Read more
64407564MMY3002 (MonumenTAL-3) - A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy
Read more
EAA181 - Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Read more
S1925 - A Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
Read more
A051901 - A Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
Read more
S1918 - A Phase II/III Randomized Study of R-miniCHOP with or without Oral Azacitidine (CC-486) in Participants Age 75 years or Older with Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIb Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
Read more
Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
Read more

DISEASES & CONDITIONS TREATED

All Cancers and Hematological Conditions
Head and Neck Cancer

CLINICAL AFFILIATIONS

Upstate Cancer Center
750 East Adams Street
Syracuse, NY 13210
315 464-8200
Upstate Community Hospital
4900 Broad Road
Syracuse, NY 13215
315 492-5555

CLINICAL SECTION AFFILIATIONS

Medicine
Hematology and Oncology
Upstate Cancer Center
Medical Oncology

CURRENT HOSPITAL PRIVILEGES

Upstate University Hospital